Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AMB-051 by AmMax Bio for Tenosynovial Giant Cell Tumor: Likelihood of Approval
AMB-051 is under clinical development by AmMax Bio and currently in Phase II for Tenosynovial Giant Cell Tumor. According to...